Over half of the reduction in the global mortality of children under 5 years of age is linked to increased education among females of reproductive age, says a reports from the Institute for Health Metrics and Evaluation, University of Washington, published in the medical journal The Lancet. Sixteen million children under the age of five [...]
No Comments »
Filed under: Women's Health
WASHINGTON (MedPage Today) — The FDA is initiating a safety review of pioglitazone (Actos) based on preliminary data showing a possible link between use of the drug and bladder cancer. Details to follow.
No Comments »
Filed under: General Health News
(MedPage Today) — The FDA has expanded cardiac resynchronization therapy defibrillator (CRT-D) use to mild or asymptomatic heart failure, granting it a new indication for left bundle branch block.
No Comments »
Filed under: General Health News
ADELPHI, Md. (MedPage Today) — An FDA advisory committee has voted 9-5 not to recommend lorcaserin hydrochloride (Lorqess), a new weight-loss drug.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The director of the National Institutes of Health (NIH) and embryonic stem cell researchers told a Senate hearing Thursday that politics, ideology, and baseless arguments are interfering with the researchers’ ability to advance science.
No Comments »
Filed under: General Health News
ADELPHI, Md. (MedPage Today) — An FDA advisory committee has voted 9-5 not to recommend lorcaserin hydrochloride (Lorqess), a new weight-loss drug.
No Comments »
Filed under: Pharmacy News
Aradigm Corporation today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podium presentation elaborates on the pharmacokinetic parameters of ciprofloxacin in the blood and sputum samples that were observed in the healthy volunteers and non-cystic fibrosis bronchiectasis (BE) patients.
No Comments »
Filed under: Pharmacy News
Transition Therapeutics Inc. announced today that a clinical study of gastrin analogue TT-223 in combination with a Lilly proprietary GLP-1 analogue in patients with type 2 diabetes did not meet its efficacy endpoints. Given these findings, there will be no further development of TT-223.
No Comments »
Filed under: Pharmacy News
Scott & White Healthcare in Round Rock, Texas is recruiting patients for a Phase III lung cancer trial aimed at preventing the disease’s recurrence in previously treated patients. The trial will evaluate the potential of an immunotherapy called Antigen-Specific Cancer Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung Cancer (NSCLC).
No Comments »
Filed under: Pharmacy News
LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company focused on the development of innovative vaccine products, announced today that it has initiated the first clinical trial for its bivalent intramuscular (IM) norovirus vaccine candidate, marking the fourth human clinical trial in the Company’s norovirus virus-like particle (VLP) vaccine program.
No Comments »
Filed under: Pharmacy News
